You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!Submit Review
Biological Activity for AS 1842856
AS 1842856 is a potent and selective Foxo1 inhibitor (IC50 values are 33 nM at Foxo1 and >1 μM at Foxo3a and Foxo4); decreases Foxo-mediated promoter activity by 70%, 20% and 3% at Foxo1, Foxo4 and Foxo3, respectively. Regulates gluconeogenesis both in vitro and in vivo. Attenuates fasting plasma glucose level in diabetic db/db mice. Also suppresses autophagy, adipocyte differentiation and soluble guanylyl cyclase expression. Also inhibits STAT3 signaling in NSCLC. Orally bioavailable.
Technical Data for AS 1842856
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solubility Data for AS 1842856
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|DMSO||1.74||5 with gentle warming|
Preparing Stock Solutions for AS 1842856
The following data is based on the product molecular weight 347.39. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|0.05 mM||57.57 mL||287.86 mL||575.72 mL|
|0.25 mM||11.51 mL||57.57 mL||115.14 mL|
|0.5 mM||5.76 mL||28.79 mL||57.57 mL|
|2.5 mM||1.15 mL||5.76 mL||11.51 mL|
References for AS 1842856
References are publications that support the biological activity of the product.
Nagashima et al (2010) Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol.Pharmacol. 78 961 PMID: 20736318
Liu et al (2016) FoxO1 antagonist suppresses autophagy and lipid droplet growth in adipocytes. Cell Cycle 15 2033 PMID: 27260854
Galley et al (2019) Antagonism of forkhead box subclass O transcription factors elicits loss of soluble guanylyl cyclase expression. Mol.Pharmacol. 95 629 PMID: 30988014
If you know of a relevant reference for AS 1842856, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: AS 1842856, AS 1842856 supplier, AS1842856, Potent, selective, FOXO1, inhibitors, inhibits, gluconeogenesis, diabetic, diabetes, orally, bioavailable, forkhead, box, O, family, soluble, guanylyl, cyclase, autophagy, differentiation, adipocytes, Other, Transcription, Factors, Guanylyl, Cyclase, Differentiation, Products, Autophagy, 4265, Tocris Bioscience
1 Citation for AS 1842856
Citations are publications that use Tocris products. Selected citations for AS 1842856 include:
Hye Jung et al (2022) P2Y2R-Mediated PAK1 Activation Is Involved in ESM-1 Overexpression in RT-R-MDA-MB-231 through FoxO1 Regulation. Cancers (Basel) 14 PMID: 36077661
Do you know of a great paper that uses AS 1842856 from Tocris? Please let us know.
Reviews for AS 1842856
There are currently no reviews for this product. Be the first to review AS 1842856 and earn rewards!
Have you used AS 1842856?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image